Label Image (Lbl500904872)
Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-4872
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-4872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Valsahctz Figur1)
This document appears to be a graph showing the probability of achieving a systolic blood pressure of less than 140 mmHg after a certain period of time. The graph displays various medications prescribed, along with their dosages, and the percentage of patients who achieved the desired blood pressure level.*
Figure 2-3-4 (Valsahctz Figure2 3 4)
This is a medical document with graphs showing the probability of achieving a diastolic blood pressure below 90mmHg at week 8 for patients taking Valsartan and Hydrochlorothiazide tablets 2025mg. It also shows the probability of achieving a systolic blood pressure below 130mmHg and a diastolic blood pressure below 80mmHg at week 8 for patients taking the same medication. There are also graphs showing the baseline SBP and baseline DBP.*
Structure (Valsahctz Hctz)
Structure (Valsahctz Valsa)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
